Possible association between the observed cyclosporine-induced upregulation of in vitro immune functions and posttransplantation lymphoproliferative disorders.
Degiannis
D
D
Hornung
N
N
D001402:B-Lymphocytes / Q000276:immunology*; D002472:Cell Transformation, Viral; D002478:Cells, Cultured; D016572:Cyclosporine / Q000494:pharmacology*; D016027:Heart Transplantation / Q000009:adverse effects / Q000276:immunology*; D004854:Herpesvirus 4, Human; D006801:Humans; D066298:In Vitro Techniques; D015850:Interleukin-6 / Q000378:metabolism; D008232:Lymphoproliferative Disorders / Q000209:etiology / Q000276:immunology*; D017455:Receptors, IgE / Q000378:metabolism*; D015854:Up-Regulation / Q000187:drug effects
D015850:Interleukin-6; D017455:Receptors, IgE; D016572:Cyclosporine